Your browser doesn't support javascript.
loading
Intraocular Pressure Decrease Does Not Affect Blood Flow Rate of Ophthalmic Artery in Ocular Hypertension.
Jóhannesson, Gauti; Qvarlander, Sara; Wåhlin, Anders; Ambarki, Khalid; Hallberg, Per; Eklund, Anders; Lindén, Christina.
Afiliación
  • Jóhannesson G; Department of Clinical Sciences, Ophthalmology, Umeå University, Umeå, Sweden.
  • Qvarlander S; Wallenberg Center for Molecular Medicine, Umeå University, Umeå, Sweden.
  • Wåhlin A; Department of Radiation Sciences, Biomedical Engineering, Umeå University, Umeå, Sweden.
  • Ambarki K; Centre for Biomedical Engineering and Physics, Umeå University, Umeå Sweden.
  • Hallberg P; Department of Radiation Sciences, Biomedical Engineering, Umeå University, Umeå, Sweden.
  • Eklund A; Centre for Biomedical Engineering and Physics, Umeå University, Umeå Sweden.
  • Lindén C; Umeå Center for Functional Brain Imaging, Umeå University, Umeå, Sweden.
Invest Ophthalmol Vis Sci ; 61(12): 17, 2020 10 01.
Article en En | MEDLINE | ID: mdl-33074299
ABSTRACT

Purpose:

To investigate if decrease of IOP affects the volumetric blood flow rate in the ophthalmic artery (OA) in patients with previously untreated ocular hypertension.

Methods:

Subjects with untreated ocular hypertension (n = 30; mean age 67 ± 8 years; 14 females) underwent ophthalmologic examination and a 3-Tesla magnetic resonance imaging investigation. The magnetic resonance imaging included three-dimensional high-resolution phase-contrast magnetic resonance imaging to measure the OA blood flow rate. The subjects received latanoprost once daily in the eye with higher pressure, the untreated eye served as control. The same measurements were repeated approximately 1 week later.

Results:

The mean OA blood flow rate before and after treatment was 12.4 ± 4.4 and 12.4 ± 4.6 mL/min in the treated eye (mean ± SD; P = 0.92) and 13.5 ± 5.2 and 13.4 ± 4.1 mL/min in the control eye (P = 0.92). There was no significant difference between the treated and control eye regarding blood flow rate before (P = 0.13) or after treatment (P = 0.18), or change in blood flow rate after treatment (0.1 ± 3.1 vs. -0.1 ± 4.0 mL/min, P = 0.84). Latanoprost decreased the IOP by 7.2 ± 3.1 mm Hg in the treated eye (P < 0.01).

Conclusions:

The results indicate that a significant lowering of IOP does not affect the blood flow rate of the OA in ocular hypertension subjects. The ability to maintain blood supply to the eye independent of the IOP could be a protective mechanism in preserving vision in subjects with ocular hypertension.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Arteria Oftálmica / Hipertensión Ocular / Presión Intraocular Tipo de estudio: Observational_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest Ophthalmol Vis Sci Año: 2020 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Arteria Oftálmica / Hipertensión Ocular / Presión Intraocular Tipo de estudio: Observational_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest Ophthalmol Vis Sci Año: 2020 Tipo del documento: Article País de afiliación: Suecia